Alpha1-antitrypsin deficiency;α1-Pi-Mangel Weltgesundheitsorganisation

Pneumologie

Volumn 51, Issue 9, 1997, Pages 885-918

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PHENOTYPE; PHYSIOLOGY; POPULATION GENETICS; PRESCHOOL CHILD; PROGNOSIS; REVIEW; RISK FACTOR; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ALLELES; ALPHA 1-ANTITRYPSIN DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GENETICS, POPULATION; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MASS SCREENING; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 0031226450     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (175)

1. 1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15 (1963) 132-140
2. 1-antitrypsin deficiency. Acta Med. Scand. 432 (1965) 1-85
3. Travis, J., G. S. Salvesen: Human plasma proteinase inhibitors. A Rev. Biochem. 52 (1983) 655-709
4. Carrell, R. W., D. R. Boswell: Serpins: the superfamily of plasma serine proteinase inhibitors. In: Barrett, A., G. Salves (eds.): Proteinase Inhibitors. Eisevier Biomedical Press, Amsterdam (1986) pp. 403-419
5. Potempa, J., E. Korzus, J. Travis: The serpin family of proteinase inhibitors: structure function and regulation.]. Biol. Chem. 269 (1994) 15 957-15 960
6. 1-antitrypsin for structure and function of serpins. Biochemistry 28 (1989) 8951-8966
7. Engh, R. A., R. Huber, W. Bode, A. J. Schulze: Divining the serpin inhibition mechanism: a suicide "spinge"? Trends in Biotech. B (1995) 503-510
8. Carrell, R. W., P. E. SteIn: The biostructural pathology of the serpins (1996) (in press)
9. Stein, P. E., R. W. Carrell: What do dysfunctional serpins tell us about molecular mobility and disease? Nature Struct. Biol. 2 (1995) 96-114
10. 1-antitrypsin. Nature 298 (1982) 329-334
11. 1-antitrypsin PiZ. FEBS Lett 65 (1976) 195-197
12. 1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc. Natl. Acad. Sci. USA 73 (1976) 1324-1328
13. 39 ÆCys). Hum. Genet. 84 (1989) 55-58
14. 1-antitrypsin. Am. J. Hum. Genet. 44 (1989) 894-902
15. iiyama (Serine53 (TCC) to phenylalanine 53 (TCC)). J. Biol. Chem. 266 (1991) 12 627-12 632
16. 1-antitrypsin causes a protein folding defect. Nature Struct. Biol. 2 (1995) 363-367
17. 1-antitrypsin variant. J. Biol. Chem. 265 (1990) 14 001-14 007
18. 1-antitrypsin accumulation in the liver. Nature 357 (1992) 605-607
19. 53 ÆPhe): further evidence for intracellular loop-sheet polymerisation. J. Biol. Chem. 268 (1993) 15 333-15335
20. Sveger, T.: Liver disease in alpha,-antitrypsin deficiency detected by screening of 200,000 infants. N. Engl. J. Med. 294 (1976) 1316-1321
21. 1-antitrypsin deficiency in early childhood. Pediatrics 62 (1978) 22-25
22. th ed. McGraw-Hill, Inc., New York 1995
23. 1-antitrypsin deficiency and related disorders. Princ. Prac. Med. Genet. 2 (1983) 911
24. 1-proteinase inhibitor protein. Disease Markers 3 (1985) 135
25. 1-antitrypsin-deficient children. Pediatr. Res. 19 (1985) 834
26. 1-antitrypsin deficiency in childhood. J. Pediatr. 88 (1976) 19
27. 1-antitrypsIn: Electrophoretic variation and DNA haplotypes. Am. J. Hum. Genet. 44 (1989) 844
28. 1-antitrypsin associated with deficiency. In: Allen, R. C., P. Arnaud (eds.): Electrophoresis, Proc. Third Int. Conference on Electrophoresis. De Gruyter, New York (1981) 505-510
29. 1-antitrypsin indicate a single origin for deficiency allele PIZ. Nature 316 (1985) 79
30. 1-antitrypsin gene. Am. J. Hum Genet. 41 (1987) 891
31. 1-antitrypsin gene in normal subjects and in patients with pulmonary emphysema. J. Med. Genet. 24 (1987) 47
32. 1-antitrypsin deficiency. Am.J. Hum. Genet. 55 (1994) 126-133
33. 1-antitrypsin deficiency with special reference to non-index cases. Thorax 49 (1994) 695-698
34. 1-antitrypsin (null homozygotes). Am. Rev. Respir. Dis. 137 (1988) 371-375
35. Jack, C. I., C. C. Evans: Three cases of alpha-1-antitrypsin deficiency in the elderly. Postgrad. Med. J. 67 (1991) 840-842
36. 1-antitrypsin deficiency. PiZ. Acta Med. Scand. 204 (1978) 345-351
37. Buist, A. S. T., B. Burrows, S. Eriksson, C. Mittman, M. Wu: The natural history of air-flow obstruction in PiZ emphysema. Am. Rev. Resp. Dis. 127 (suppl) (1982) s43-s50
38. 1-antritrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi Type Z. Br. J. Dis. Chest 77 (1983) 14-27
39. nd edn. Oxford University Press, Oxford (1991) pp. 435-450
40. Schwartz, J.: Air pollution and hospital admissions for the elderly in Detroit, Michigan. Am.J. Respir. Crit. Care Med. 150 (1995) 648-655
41. Higgins, I. T. T. et al.: Chronic respiratory disease in mining communities in Marion County, West Virgina. Br. J. Ind. Med. 25 (1968) 165-175
42. Sunyer, J. et al.: Effects of urban air pollution on emergency room admissions for chronic obstructive pulmonary disease. Am. J. Epidmiol. 134 (1991) 277-286
43. Abbey, D. E. et al.: Estimated long-term ambient concentrations of PM10 and development of respiratory symptoms in a nonsmoking population. Arch. Environ. Health 50 (1995) 139-152
44. Bakke, P. S. et al.: Prevalence of obstructive lung disease in a general population, relation to occupational title an exposure to some airborne agents. Thorax 46 (1991) 863-870
45. Oxman, A. D. et al.: Occupational dust exposure and chronic obstructive pulmonary disease. A systemic overview of the evidence. Am. Rev. Respir. Dis. 148 (1993) 38-48
46. Shaheen, S. O. et al.: The relationship between pneumonia in early childhood an impaired lung function in late adult life. Am. J. Respir. Care Med. 149 (1994) 616-619
47. Shaheen, S. O. et al.: Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? Am. J. Respir. Care Med. 151 (1995) 1649-1652
48. Monso, E. et al.: Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am. J. Respir. Crit. Care Med. 152 (1995) 1316-1320
49. Saint, S. et al.: Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA 273 (1995) 857-960
50. Silverman, E. K., J. P. Miletich, J. A. Pierce, L. A. Sherman, S. K. Endicott, G. J. Broze Jr., E. J. Campbell: Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am. Rev. Respir. Dis. 140 (1989) 961-966
51. Redline, S., P. V. Tishler, F. I. Lewitter, I. B. Tager, A. Munoz, F. E. Speizer: Assessment of genetic and nongenetic influences on pulmonary function. A twin study. Am. Rev. Respir. Dis. 135 (1987) 217
52. Silverman, E. K., J. A. Pierce, M. A. Province, D. C. Rao, E. U. Campbell: Variability of pulmonary function in alpha-1-antitrypsin deficiency: Clinical correlates. Ann. Int. Med. 111 (1989) 982
53. Silverman, E. K., M. A. Province, E. J. Campbell: J. A. Pierce, D. C. Rao: Variability of pulmonary function in alpha-1-antitrypsin deficiency; residual family resemblance beyond the effect of the Pi locus. Hum. Hered. 40 (1990) 34-355
54. Kalsheker, N. A., G. L Watkins, S. Hill, K. Morgan, R. A. Stockley, R. B. Pick: Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. Dis. Markers 8 (1990) 151-157
55. 1-antitrypsin gene commonly associated with chronic obstructive airway disease. European J. Clin. Invest. 22 (1992) 134-137
56. Sokol, R. J., J. E. Heubi, C. Negraw, W. F. Balistreri: Correction of vitamin E deficiency in children with chronic cholestasis. II. Effect on gastrointestinal and hepatic function. Hepatology 6 (1986) 1263
57. 1-antitrypsin deficiency. N. Engl. J. Med. 287 (1972) 1274
58. 1-antitrypsin deficiency. Am. J. Med. 74 (1983) 221
59. Snider, G. L.: Emphysema: the first two centuries - and beyond; a historical overview, with suggestions for future research: Part 2. Am. Rev. Respir. Dis. 146(1992) 1615-1722
60. Thurlbeck, W. M.: Chronic airflow obstruction. In: Thurlbeck, W. M. (ed.): Pathology of the Lung, COPD. Thieme Medical Publishers, Inc., New York (1988) pp. 519-576
61. Wright, J. L., J. E. Hobson, B. Wiggs, P. D. Pare, J. C. Hogg: Airway inflammation and peribronchiolar attachments in the lung of nonsmokers, current and ex-smokers. Lung 166 (1988) 277-286
62. Janoff, A.: Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis. 132 (1985) 417-433
63. Talamo, R. C., C. E. Langley, C. E. Reed, S. Makino: Alpha-1-antitrypsin deficiency: a variant with no detectable alpha-1-antitrypsin. Science 181 (1973) 70
64. Carver, R. I. Jr., J.-F. Mornex, T. Nukiwa, M. Brantly, M. Courtney, J. P. LeCocq, R. G. Crystal: Alpha-1-antitrypsin deficiency and emphysema caused by homozygous inheritance of non-expressing alpha-1-antitrypsin genes. N. Engl. J. Med. 314 (1986) 762
65. Wevers, M. D., A. Casolaro, S. E. Sellers, S. C. Swayze, K. M. McPhaul, J. T. Wittes, R. G. Crystal: Replacement therapy of alpha-1-antitrypsin deficiency associated with emphysema. N. Engl. J. Med. 316 (1987) 1055-1062
66. Cook, L., E. D. Janud, S. Brenton, E. Tai, J. Burdon: Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysema. Aust. NZ J. Med. 24 (1994) 263-269
67. Barker, A. F., R. G. D'Silva, S. A. Buist: Lung function and A1AT deficiency. In: Crystal, R. G. (ed.): Alpha-1-antitrypsin Deficiency; Biology, Pathogenesis, Clinical Manifestations, Therapy. Marcel Dekker, Inc., New York (1996) pp. 245-257
68. Snider, G. L., E. C. Lucey, T. G. Christensen, P. J. Stone, J. D. Calore, A. Catanese, C. Franzblau: Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am. Rev. Respir. Dis. 129 (1984) 155-160
69. Stockley, R. A., H. M. Morrison, J. A. Kramps, Dijkman: Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment. Thorax 41 (1986) 442-447
70. Sommerhoff, C. P., J. A. Nadel, C. B. Basbaum, G. H. Caughey: Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J. Clin. Invest. 85 (1990) 682-689
71. Brantly, M., T. Nukiwa, R. G. Crystal: Molecular basis of alpha-1-antitrypsin deficiency. Am. J. Med. 84 (Suppl. 6A) (1988) 13-31
72. Wall, M., E. Moe, J. Eisenberg, M. Powers, N. Buist, A. S. Buist: Long term follow-up of al cohort of children with alpha-1-antitrypsin deficiency. J. Pediatr. 116 (1990) 248-251
73. Sveger, T.: Prospective study of children with alpha-1-antitrypsin deficiency: eight year follow-up. J. Pediatr. 104 (1985) 91-94
74. Sveger, T., E. Plitulainen, M. Arborelius: Clinical features and lung function in 18 year old adolescents with alpha-1-antitrypsin deficiency. Acta Paediatrica 84 (1995) 815-816
75. The Alpha-1-antitrypsin Deficiency Registry Study Group. Prepared by: Schluchter, M. D., A. R. Barker, R. G. Crystal, R. A. Robbins, J. M. Stocks, J. K. Stoller, M. C. Wu: A registry of patients with severe deficiency of alpha-1-antitrypsIn: Design and methods: Chest 106 (1994) 1223-1233
76. Janus, E. D., N. T. Phillips, R. W. Carrell: Smoking lung function, and alpha-1-antitrypsin deficiency. Lancet 1 (1985) 152-154
77. Eriksson, S.: Studies in alpha-1-antitrypsin deficiency. Acta Med. Scand. 1771 (1965) 1-85
78. Brantly, M. L., L D. Paul, B. H. Miller, B. H. Falk, M. Wu, R. G. Crystal: Clinical features and history of the destructive lung disease associated with alspha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am. Rev. Respir. Dis. 138 (1988) 327-336
79. Gishen, P., A. J. S. Saunders, M. J. Tobin, D. C. S. Hutchinson: Alpha-1-antitrypsin deficiency: The radiological features of pulmonary emphysema in subjects of Pi-type Z and Pi-type SZ: A survey by the British Thoracic Association. Clin. Radiol. 33 (1982) 371-377
80. Lieberman, J., B. Winter, A. Sastre: Alpha-1-antitrypsin Pi-types in 965 COPD patients. Chest 89 (1986) 370-373
81. National Centre for Health Statistics: National Health Interview Survey, 1986. Statistical Compendium on Adult Diseases. American Lung Association (1987) p. 31
82. O'Brien, M. L., N. R. M. Buist, W. H. Murphy: Neonatal screening for alpha-1-antitrypsin deficiency. J. Pediatr. 92 (1979) 1006-1010
83. Spence, W. C., J. E. Morris, K. Pass, P. D. Murphy: Molecular confirmation of alpha-1-antitrypsin genotypes in newborn dried blood specimens. Biochem. Med. Met. Biol. 50 (1993) 233-240
84. Stoller, J. K., P. Smith, P. Yang, J. Spray: Physical and social impact of alpha-1-antitrypsin deficiency: Results of a mail survey of the readership of a national newsletter. Cleve Clin. J. Med. 61 (1995) 461-467
85. Fallat, R.J.: Reactive airway disease and A1AT deficiency. In: Crystal, R. G. (ed.): Alpha-1-Antitrypsin Deficiency; Biology Pathogenesis, Clinical Manifestations, Therapy. Marcel Dekker, Inc., New York (1996) pp. 259-279
86. Colp, C., J. Pappas, D. Moran, J. Lieberman: Variants of alpha-1-antitrypsin in Puerto Rican children with asthma. Chest 103 (1993) 812-815
87. Wiggs, B. R., C. Bosken, P. D. Pare, J. C. Hogg: A model of airway narrowing in asthma and chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 145 (1992) 1251-1258
88. Jones, D. K., D. Godden, P. Cavanagh: Alpha-1-antitrypsin deficiency presenting as bronchiectasis. Br. J. Dis. Chest 79 (1985) 301-304
89. El-Kassimi, F. A., A. S. Warsy, A. Uz-Zaman, D. K. Pillai: Alpha-1-antitrypsin serum levels in widespread bronchiectasis. Respir. Med. 83 (1989) 119-121
90. Shin, M. S., K.-J. Ho: Bronchiectasis in patients with alpha-1-antitrypsin deficiency: A rare occurrence? Chest 104 (1993) 1384-1386
91. Sveger, T., E. Pültulainen, M. Arborelius: Lung function in adolescents with alpha-1-antitrypsin deficiency. Acta Paediatrica 83 (1994) 1170-1173
92. Hutchison, D. C. S., M. J. Tobin, D. Cooper, D. Lowe: Longitudinal studies in alpha-1-antitrypsin deficiency: A survey by the British Thoracic Society. In: Taylor, J. C., C. Mittman (eds.): Pulmonary emphysema and proteolysis. Academic Press, New York (1987) pp. 7-15
93. Wu, M. C., S. Eriksson: Lung function, smoking, and survival in severe alpha-1-antitrypsin deficiency, PiZZ. J. Clin. Epidemiol. 41 (1988) 1157-1165
94. Seersholm, N., A. Kok-Jensen: Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha-1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 151 (1995) 369-373
95. Silverman, E. K., M. A. Province, D. C. Rao, J. A Pierce, E. J. Campbell: A family study of the variability of pulmonary function in alpha-1-antitrypsin deficiency. Quantitative phenotypes. Am. Rev. Respir. Dis. 142 (1990) 1015-1021
96. 1 among patients with severe hereditary alpha-1-antitrypsin deficiency type PiZ. Am. J. Respir. Crit. Care Med. 152 (1995) 1922-1925
97. Propst, T., A. Propst, O. Dietze, G. Judmaier, H. Braunsteiner, W. Vogel: Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency. J. Hepatology 21 (1994) 1006-1011
98. Deutsch, J., H. Becker, L. Auböck: Histopathological features of liver disease in alpha-1-antitrypsin defeciency. Acta Paediatr. 393 (1994) 8-12
99. Sveger, T., S. Eriksson: The liver in adolescents with alpha-1-antitrypsin deficiency. Hepatology 22 (1995) 514-517
100. 1-antitrypsin deficiency: a previously unrecognized inherited disorder. J. Lab. Clin. Med. 73 (1969) 934-939
101. Eriksson, S., J. Carlson, R. Velez: Risks for cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N. Engl. J. Med. 315 (1986) 736-739
102. 1-antitrypsin deficiency (PiZZ). (in press)
103. Propst, T., A. Propst, O. Dietze, G. Judmeier, H. Braunsteiner, H. Vogel: High prevalence of viral infection in adults with homozygous and heterozygous alpha-1-antitrypsin deficiency and chronic liver disease. Ann. Intern. Med. 117 (1992) 641-654
104. Hussain, M., G. Mietli-Vergani, A. P. Mowat: Alpha-1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment. J. Inher. Metab. Dis. 14 (1991) 497-511
105. 1-antitrypsin deficiency emphysema and liver disease: genetic basis and strategies for therapy. J. Clin. Invest. 85 (1990) 1343-1352
106. Edmonds, B. K., J. A. Hodge, R. L. Rietschel: Alpha-1-antitrypsin deficiency-associated panniculitis: Case report and review of the literature. Pediatr. Dermatol. 8 (1991) 296-299
107. Irvine, C., V. Neild, C. Stephens, M. Black: Case reports: Alpha-1-antitrypsin deficiency panniculitis. J. Royal Soc. Med. 83 (1990) 743-744
108. Schievink, W. I., J. Björnsson, J. E. Parisi, U. B. S. Prakash: Arterial fibromuscular dysplasia associated with severe alpha-1-antitrypsin deficiency. Mayo Clin. Proc. 69 (1994) 1040-1043
109. Cox, D. W.: Alpha-1-antitrypsIn: A guardian of vascular tissue. Mayo Clin. Proc. 69 (1994) 1123-1124
110. Owen, M. C., S. O. Brennan, J. H. Lewis, R. W. Carrell: Mutation of antitrypsin to antithrombIn: Alpha-1-antitrypsin Pittsburgh (358 Met'Arg), a fatal bleeding disorder. N. Engl. J. Med. 309 (1983) 695-698
111. 1-antitrypsin experience. Thorax 43 (1988) 505-507
112. Buist, A. S., B. Burrows, A. Cohen et al.: Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. Am. Rev. Resp. Dis. 140 (1989) 1494
113. Hubbard, R. C., S. Sellers, D. Czerski et al.: Biochemical efficacy and safety of monthly augmentation therapy for alpha-1-antitrypsin deficiency. J. Am. Med. Ass. 260 (1988) 1259
114. 1-antitrypsin infusion augmentation for treatment of deficiency. Am. Rev. Resp. Dis. 139 (1989) A122
115. Casolaro, M. A., G. Fells, M. Wewers et al.: Augmentation of lung antineutrophil elastase capacity with recombinant human a-1-antitrypsin. J. Appl. Physiol. 63 (1987) 2015
116. 115a Wu, M. C., S. Eriksson: Lung function, smoking and survival in servere alpha-1-antitrypsin deficiency, PiZZ. J. Clin. Epidemiology 41 (1988) 1157
117. 1-Pi-deficiency: comparison of 161 untreated Danish and 235 German patients receiving augmentation therapy. Am. J. Resp. Crit. Care Med. 151 (4) (1995) A835
118. Smith, R. M., L D. Traber, D. L Traber et al.: Pulmonary deposition and clearance of aerosolized alpha-1- proteinase inhibitor administered to dogs and to sheep. J. Clin. Invest. 84 (1989) 1145
119. 1-antitrypsin. Ann. Intern. Med. 111 (1989) 206
120. 1-antitrypsin deficiency. J. Clin. Invest. 84 (1989) 1349
121. 1 Pi deficiency. Am. J. Respir. Crit. Care Med. 153 (1996) A400
122. 1-protease inhibitor in normal volunteers. Am. J. Respir. Crit. Care Med. 155 (1997) 536-541
123. Boris-Lawrie, K. A., H. M. TemIn: Recent advances in retrovirus technology. Curr. Opin. Genet. Dev. 301 (1993) 353-362
124. 1-antitrypsin gene in vivo. Science 237 (1987) 762-764
125. Kolodka, T. M., M. Finegold, S. L. C. Woo: Hepatic gene therapy: efficient retroviral-nnediated gene transfer into rat hepatocytes in vivo. Somat. Cell. Mol. Genet. 19 (1993) 491-497
126. 1-antitrypsin deficiency. Clin. Res. 37 (1989) 578A
127. Strauss, S. E.: In: Ginsberg, H. S. (ed.): The adenoviruses. Plenum Press, New York (1984) pp. 451-496
128. 1-antitrypsin gene to the lung epithelium in vivo. Science 252 (1991) 431-434
129. Jaffe, H. A., C. Danel, G. Longenecker, M. Metzger, Y. Setoguchi, M. A. Rosenfeld, T. W. Gant, S. S. Thorgeirsson, L. D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J.-P. Lecoq, R. G. Crystal: Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1 (1992) 368-371
130. Setoguchi, Y., H. A. Jaffe, C. S. Chu, R. G. Crystal: Intraperitoneal in vivo gene therapy to deliver alpha-1-antitrypsin to the systemic circulation. Am. J. Respir. Cell Mol. Biol. 10 (1995) 369-377
131. Crystal, R. G., N. G. McElvany, M. A. Rosenfeld, C.-S. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, C. Danel: Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8 (1994) 42-51
132. McElvaney, N. G., R. G. Crystal: IL-6-release associated with airway administration of human CFTR cDNA adenovirus vector. Nat. Med. 1 (195) 182-184
133. 1-antitrypsin gene to lungs of rabbits. Am. J. Respir. Cell Mol. Biol. 10 (1994) 24-29
134. Michael, S. I., D. T. Curiel: Strategies to achieve targetted gene delivery via the receptor-mediated endocytosis pathway. Gene Therapy 1 (1994) 223-232
135. Sandhaus, R. A.: Elastase may play an central role in the neutrophil migration through connective tissue. In: Taylor, J. C., C. Mittman (eds.): Pulmonary Emphysema and Proteolysis. Academic Press, Orlando (1987) pp. 227-233
136. Bangolore, N., J. Travis, V. C. Onunka et al.: Identification of the primary antimicrobial domains in human neutrophil cathepsin G.J. Biol. Chem. 265 (1990) 13584
137. Ayars, G. H., L. C. Altman, H. Rosen, T. Doyle: The injurious effect of neutrophils on pneumocytes in vitro. Am. J. Respir. Dis. 130 (1984) 964-973
138. Lucey, E. C., P. J. Stone, G. L. Snider: Consequences of proteolytic injury. In: Crystal, R. G., J. B. West (eds.): Lung Injury. Raven Press Ltd., New York (1992) pp. 29-41
139. 1-antitrypsin treatment for cystic fibrosis. Lancet 337 (1991) 392-394
140. Sallenave, J.-M., J. Shulmann, J. Crossley et al.: Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/Elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11 (1994) 733-741
141. Stockley, R. A.: The pathogenesis of chronic obstructive lung diseases: implications for therapy. Q. J. Med. 88 (1995) 141-146
142. Richman-Eisenstat, J. B. et al.: Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway disease. Am. J. Physiol. (Lung Cell Mol. Physiol. 8) 264 (1993) L413-L418
143. Di Stefano, A., P. Maestrelli, A. Roggeri, G. Turato, S. Calabro, A. Potena, C. Mapp, A. Ciaccia, L. Covacev, L. Fabbri, M. Saetta: Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am. J. Respir. Crit. Care Med. 149 (1994) 830-810
144. Stockley, R. A., D. Burnett: Alpha-1-antritrypsin and leukocyte elastase in infected and noninfected sputum. Am. Rev. Resp. Dis. 120 (1979) 1081-1086
145. Stockley, R. A., S. L. Hill, H. M. Morrison, C. M. Starkie: Elastinolytic activity in sputum and its relation to purulence and lung function in patients with bronchiectasis. Thorax 39 (1984) 408-413
146. Lomas, D. A., S. R. Stone, C. Llevellyn-Jones, M. T. Keogan, Z. Wang, H. Reuben, R. W. Carrell, R. A. Stockley: The control of neutrophil chemotaxis of inhibitors of Cathepsin G in chymotrypsin. J. Biol. Chem. 270 (1995) 23437-23443
147. 1-antitrypsin by electrofocusing. Clin. Chem. 28 81982) 219-225
148. 1-antitrypsin followed by phenotyping of deficient speciments by isoelectric focusing. Screening 3 (1994) 23-31
149. 1-antitrypsin deficiency: A need for screening? Screening 1 (1992) 195-201
150. 1-antitrypsin deficiency. Hepatology 22 (1995) 514-517
151. Seersholm, N., A. Dirksen, A. Kok-Jensen: Airways obstruction and two year survival in patients with severe alpha-1-antitrypsin deficiency. Eur. Respir. J. 7 (1994) 1985-1987
152. Schleusener, A., R. C. Talamo, J. A. P. Pare, W. M. Thurlbeck: Familial emphysema. Am. Rev. Respir. Dis. 98 (1968) 692-696
153. Orell, S. R., P. Mazodier: Pathological findings in alpha-1-antitrypsin deficiency. In: Mittmann, C. (ed.): Pulmonary Emphysema and Proteolysis. Academic Press, New York (1972) 69-89
154. Cohen, K. L., P. E. Rubin, R. E. Echevarria, H. L. Sharp, P. O. Teague: Alpha-1-antitrypsin deficiency, emphysema and cirrhosis in an adult. Ann. Int. Med. 78 (1973) 227-232
155. Glasgow, J. F., M. J. Lymch, A. Hercz, H. Levison, A. Sass-Kortsak: Alpha-1-antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs. Am. J. Med. 54 (1973) 181-194
156. Varpela, E., Y. Salorinne: Respiratory disease profile in 22 patients with alpha-1-antitrypsin deficiencies. Scand. J. Resp. Dis. Suppl. 89 (1974) 251-260
157. d'Almaine-Semple, P., C. B. Reid, W. S. Thompson: Widespread panacinar emphysema with alpha-1 -antitrypsin deficiency. Br. J. Dis. Chest 74 (1980) 289-295
158. Kueppers, F., L F. Black: Alpha-1-antitrypsin and its deficiency. Am. Rev. Respir. Dis. 110 (1974) 176-194
159. Rawlings, W. Jr., P. Kreiss, D. Levy et al.: Clinical, epidemiologic and pulmonary function studies in alpha-1-antitrypsin deficient subjects of PI* Z type. Am. Rev. Respir. Dis. 114 (1976) 945-953
160. Black, L., F. Kueppers: Alpha-1-antitrypsin deficiency in nonsmokers. Am. Rev. Respir. Dis. 117 (1978) 421-428
161. Hutchison, D. C. S., C. E. Barter, P. J. L. Cook, J. W. Laws, N. A. Martelli, P. Hugh-Jones: Severe pulmonary emphysema: A comparison of patients with and without alpha-1-antitrypsin deficiency. Q. J. Med. 41 (1972) 301-315
162. Fagerhol, M. K., H. E. Hauge: Serum Pi types in patients with pulmonary diseases. Acta Allergologica 24 (1969) 107-114
163. Szczelik, A., B. Turowska, G. Czerniawska-Mysik, B. Opolska, E. Nizankowska: Serum alpha-1-antitrypsin in bronchial asthma. Am. Rev. Respir. Dis. 109 (1974) 487-490
164. Werner, P., J. S. Hyde, R. V. Lourenco, R. C. Talamo: Alterations in lung function in children with chronic asthma and Pi variants. J. Allergy Clin. Immunol. 55 (1975) 128-129
165. Katz, R. M., J. Liebermann, S. C. Siegel: Alpha-1-antitrypsin levels and prevalence of Pi-variant phentoypes in asthmatic children. J. Allergy Clin. Immunol. 57 (1976) 41
166. Schwartz, R. H., J. D. Van Ess, D. E. Johnstone, E. M. Dreyfuss, M. Ali Abrishami, H. Chai: Alpha-1-antitrypsin in childhood asthma. J. Allergy Clin. Immunol. 59 (1977) 31-34
167. Hyde, J. S., P. Werner, C. M. Kumar, B. S. Morre: Protease inhibitor variants in children and young adults with chronic asthma. Ann. Allerg. 43 (1979) 8-13
168. Kabiraj, M. U., G. Simonsson, S. Groth, A. Bjorklund, K. Bulow, S. E. Lindell: Bronchial reactivity, smoking and alpha-1-antitrypsIn: A population-based study of middle-aged men. Am. Rev. Respir. Dis. 126 (1982) 864-869
169. Townley, R. G., J. G. Southard, P. Radford, R. J. Hopp, A. K. Bewtra, L. Ford: Association of MS Pi phenotype with airway hyperresponsiveness. Chest 98 (1990) 594-599
170. Gaillard, M. C., A. Kilroe-Smith, C. Nogueira, D. Dunn, T. Jenkins, B. Fine, J. Kallenbach: Alpha-1-protease inhibitor in bronchial asthma: Phenotypes and biochemical characteristics. Am. Rev. Respir. Dis. 145 (1992) 1311-1315
171. Longstreth, G. F., S. A. Wetzmann, R. J. Browning, J. Lieberman: Bronchiectasis and homozygous alpha-1-antitrypsin deficiency. Chest 67 (1975) 233-235
172. Scott, J. H., C. L. Anderson, P. Shankar, A. Stavrides: Alpha-1-antitrypsin deficiency with diffuse bronchiectasis and cirrhose of the liver. Chest 71 (1977) 535-538
173. Casterline, C. L., R. Evans III, V. C. Battista, R. C. Talamo: Selective IgA deficiency and PiZZ-antritrypsin deficiency. Association with recurrent sinopulmonary infections, emphysema, and bronchiectasis. Chest 73 (1978) 885-886
174. Guest, P. J., D. M. Hansell: High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin. Radiol. 45 (1992) 260-266
175. Rodriguez-Cintron, W., K. Guntupalli, A. E. Fraire: Bronchiectasis and homozygous (PiZZ) alpha-1-antitrypsin deficiency in a young man. Thorax 50 (1995) 424-425